The studies of many investigators have led to a unified concept of the megaloblastic anemias as a single morphologic entity due to defective nucleoprotein synthesis from various causes. The vast majority of patients with megaloblastic anemia have been found to have deficiency of vitamin B12, of folic acid, or of both vitamins. For this reason, the possible interrelations of these two vitamins have long piqued the curiosity of investigators (1, 2) .
Orally administered or injected pteroylglutamic acid (PGA) (folic acid) has been reported to disappear rapidly into the tissues of vitamin B12-(leficient patients, as manifested by rapid disappearance of Streptococcus faecalis activity from serum and urine (3) (4) (5) (6) .
'The purpose of the present investigation was to determine whether the rapid disappearance of folic acid activity for S. faecalis from the serum of subjects with pernicious anemia reflects tissue depletion of folic acid, as believed by prior investigators, or instead indicates inadequate utilization of folic acid due to vitamin B12 deficiency. Prior results of part of these studies (7) (8) (9) (10) suggest that the latter is the case. Incidental to these observations, the effect of intravenously administered PGA on serum vitamin B12 and on erythrocyte folic acid activity was determined.
The studies here presented elaborate on our preliminary reports (7) (8) (9) (10) , indicating that folic acid activity "piles up" in human serum in the presence of vitamin B12 deficiency. The accumulation of this folic acid activity (probably N5-methyl-tetrahydrofolic acid) provides direct evidence of deranged folic acid metabolism due to vitamin B12 deficiency. This folic acid-vitamin B12 interrelationship may explain much of the confu-* Aided in part by research grants from the National Institutes of Health, USPHS (A-795 (C4)) and (A-3853), and the National Vitamin Foundation. sion in therapy of pernicious anemia, as well as the fact that the anemias of vitamin B12 and folic acid deficiencies are hematologically identical.
MATERIALS AND METHODS
Synthetic pteroylglutamic acid 1 was diluted with saline to a concentration of 1 mg per ml. The concentration was proven by microbiologic assay with both S. faecalis and Lactobacillus casei, and the solution was stored at 4 ' C in sterile light-tight bottles.
Procedure. The subjects of the investigation were given 15 ug of PGA per kg of body weight by rapid intravenous injection (5) . Blood samples were obtained at zero time (immediately before) and at 3, 8, 15, 30, 60, 120, 240, and 1,440 minutes (24 hours) after the injection.
Serum samples were obtained in plain Vacutainers 2 and whole blood samples in heparinized Vacutainers.
Estimations of folic acid activity in serum and erythrocytes. These were carried out by microbiologic assay with L. casei and S. faecalis as previously reported (8) , using both the "standard method" (150 mg per 100 ml ascorbate) and the "aseptic addition method" (1 g per 100 ml ascorbate) (8) . The latter method has the advantages of halving the manipulations involved in preparing an assay, and allowing assay of 0. 24.9 are suggestively elevated and may indicate folic acid ingestion by normal subjects; and values > 25 mug per ml have never been found in normal subjects unless they were ingesting vitamin tablets containing folic acid.
The folic acid activity of 1 ml of erythrocytes was determined using the same methodology (8) previously applied to serum. "Reticulocyte-rich" and "reticulocyte-VICTOR HERBERT AND RALPH ZALUSKY poor" erythrocytes were prepared as follows. On the eighth day of therapy with 30 ,g of vitamin B12 daily, 100 ml of blood was obtained from Subject 5 and centrifuged. The buffy coat was discarded and the red cells were thrice washed in 0.9 per cent NaCl, discarding the topmost layer of "residual buffy coat." The middle half of the erythrocyte layer was again centrifuged to yield a "reticulocyte-rich" top layer (26 per cent reticulocytes) and a "reticulocyte-poor" bottom layer (6 per cent reticulocytes); 0.2-ml aliquots of erythrocytes were then assayed by our "standard method" (8) .
Serum vitamin B12 levels. These were determined using Euglena gracilis, var. bacillaris, by the method of Lear Erythrocyte vitamin B12 levels. The methodology of Spray (12) for extracting vitamin B12 from serum was applied to extracting the vitamin from erythrocytes. One ml of erythrocytes, 1 ml of 0.4 N acetate buffer (pH 4.5), 0.4 ml of 0.1 per cent NaCN, and 17.6 ml distilled water were autoclaved together at 1180 C for 15 minutes. After cooling and centrifugation, the supernate was assayed as if it were serum (vide supra).
In other studies (13) , this extraction procedure was shown to remove approximately 81 per cent of the total vitamin B12 radioactivity from 1 g of liver obtained at sacrifice of a baby pig who had been given daily injections of radioactive vitamin B12 for almost 2 months.
After the final injection and before sacrifice, there was a rest period of 5 days to allow equilibration of the last injections of radioactive vitamin B12 with tissue vitamin B12. (The extract contained 81 per cent and the precipitate contained 19 per cent of the total liver radioactivity.) A similar efficiency of extraction is assumed for erythrocytes, although we are not aware of studies using a radioactive marker to demonstrate this probability.
Estimation of formiminoglutainic aciduria. After ingestion of 20 g of L-histidine, urine was collected for 12 hours in a bottle containing 2 ml of concentrated HCl, and the quantity of formiminoglutamic acid (FIGLU) was estimated by a modification (14) of the electrophoretic method of Knowles, Prankerd and Westall (15) .
Clinical and laboratory criteria for diagnosis (2) . Vitamin B12 deficiency: hematologic morphologic abnormalities in the peripheral blood (macroovalocytes and hypersegmented polymorphonuclear leukocytes) and bone marrow (megaloblasts and giant metamyelocytes); serum vitamin B12 level < 100 gttg per ml.
Folic acid deficiency: same morphologic criteria as for vitamin B12 deficiency; serum folic acid activity for L. Pernicious anemia: anemia due to vitamin B12 deficiency caused by idiopathic lack of adequate intrinsic factor secretion. RESULTS
Normal subjects. In three normal subjects, folic acid activity for both L. casei and S. faecalis remained elevated for at least 4 hours after intravenous injection of PGA, returning to baseline levels some time between 4 and 24 hours after the intravenous dose ( Figure 1 and Table I , Subjects 1-3).
MVIegaloblastic anemia due to folic acid deficiency. In three such subjects, within 30 minutes after the intravenous injection of PGA, an acute rise in serum folic acid activity occurred, S. faecalis activity had fallen below 2 mjug per ml, and L.
casei activity had fallen to below 5 m/ug per ml ( Figure 2 and Table I , Subjects 7-9).
Megaloblastic anemia due to vitamin B12 deficiency. In three such subjects, serum folic acid activity for S. faecalis fell to 3 or less mug per ml of serum within 30 minutes after the acute rise produced by the intravenous PGA injection (Figure 3) . However, serum folic acid activity for L. casei remained elevated for at least 4 hours after intravenous PGA injection ( Figure 3 and Table  I , Subjects 4-6).
After the folic acid clearance study, Subject 4, who has been reported elsewhere in connection with his high FIGLU excretion (16) , was treated with 5 ug of vitamin B12 daily for 7 days, inducing a 51.9 per cent reticulocytosis and hematologic improvement. He was then allowed to relapse and, 2 months after the first clearance study (Table I , Subject 4), a second one (Table 1 , Subject 4a) was performed; the results were similar.
Immediately after the intramuscular administration of 30 jug of vitamin B12 daily for 18 days, Subject 5 cleared folic acid activity for both organisms at a rate which was relatively normal ( Megaloblastic anemia due to deficiencies of both vitamin B12 and folic acid. Two such patients were studied. Subject 11 had idiopathic steatorrhea (nontropical sprue); Subject 12 had pernicious anemia with associated folic acid deficiency (presumably due to protracted anorexia). Subject 11, who had more marked folic acid deficiency, rapidly cleared folic acid activity for both microorganisms from his blood stream. Subject 12, with less marked folic acid deficiency, cleared Folic acid activity (and vitamin B12 activity) was much higher in "reticulocyte-rich" than in "reticulocyte-poor" erythrocytes obtained during vitamin B12 therapy for pernicious anemia (Table  V) , suggesting the relative permeability to folic acid and vitamin B12 of young erythrocytes. [It has previously been observed (17) that there is an increased concentration of radioactive vitamin B12 in the stroma protein of erythrocytes during active blood regeneration in anemia in dogs.] L. casei folic acid activity of leukocytes appears to be higher than that of erythrocytes (18) .
Effect of specific therapy w~ith vitamin B12 on serum folic acid activity for L. casei. Table VI shows that serum folic acid activity falls slowly during specific therapy with daily doses of 1 Microbiologic assay with L. casei also revealed rapid disappearance of folic acid activity from the serum after intravenous injection of PGA in patients with folic acid deficiency. However, in patients with vitamin B12 deficiency, serum L. casei activity did not disappear as fast. In fact, a "plateau phenomenon" may be present, manifested by a tendency for serum L. casei activity to remain elevated well above baseline at a fairly constant level for at least 0.5 to 2 hours after the intravenous injection of PGA.
In subjects with vitamin B12 deficiency, the combination of rapid clearance of S. faecalis activity and slow clearance of L. casei activity suggests that in such subjects PGA (which is available to both S. faecalis and to L. casei) is rapidly converted, perhaps in the liver, to a form only available to L. casei. This L. casei-active form then appears to "pile up" in the serum, suggesting that vitamin B12 is required for its utilization.
During the course of therapy with daily doses of 1 (21) . This value was described in the original report as "high, but of unknown significance." In the present report, we are able to throw some light on the significance of that finding. In the present study, review of 100 consecutive patients with vitamin B12 deficiency revealed that 17 had initial serum folic acid activity for L. casei of 25 mptg per ml or more, and nine had values of 16 to 24.9 m~ug per ml (Table II) , despite frequent protracted anorexia, which would be expected to lower such activity. Waters and Mollin (22) have also observed increased serum folic acid activity for L. casei in untreated Addisonian pernicious anemia. The majority of our 100 patients had pernicious anemia. Those with serum L. casei folic acid activity < 7 mug per ml frequently had debilitating complications, which may have led to associated anorexia with inadequate ingestion of folic acid, such as chronic genitourinary tract infection, alcoholism, or marked neurologic disability due to past cerebrovascular accident. One patient also had lupus erythematosus. Serum folic acid activity < 7 mptg per ml was also frequent among the patients with vitamin B12 deficiency who did not have pernicious anemia. These were mainly patients with gastrointestinal dysfunction due to structural or functional small bowel damage, which may result in malabsorption for folic acid, and included patients with partial small intestine resection, idiopathic steatorrhea, total or subtotal gastrectomy with subsequent malabsorption, and carcinoma with abdominal metastases. Although in presumably normal subjects values of 7 to (10) .
In view of the tendency of L. casei-active folic acid activity to accumulate in the serum of subjects with vitamin B12 deficiency, it is possible that a low normal value for such activity may be present in the serum of a vitamin Bl -deficient subject with folic acid stores inadequate to sustain normal hematopoiesis, just as a normal serum iron level may be present in patients with untreated megaloblastic anemia who do not have iron stores adequate to sustain normal hematopoiesis (2) .
Recent studies (23) suggest that most of the L. casei activity in human serum is due to a material similar or identical to N5-methyl-tetrahydrofolic acid (N5-methyl THFA), the folic acid coenzyme active as an intermediate in methionine biosynthesis (24) (25) (26) (27) (28) (29) , which requires vitamin B12 in order to act (25, 26, 30, 31) . Table VII summarizes present knowledge concerning the folic acid activity for microorganisms of various folic acid analogues.
Earlier clinical investigation of patients with vitamin B12 deficiency has also provided evidence suggesting that vitamin B12 is required for normal folic acid metabolism: 1) While normally the liver folic acid stores appear to be mainly folinic acidlike material, in vitamin B12 deficiency states the stores had appeared to be mainly folic acid (32, 33) . However, more recent studies indicate that the bulk of normal liver stores may be N5-methyl THFA which is only active for L. casei (23, 28, 34, 35) . It is evident that much of the data in the literature will have to be re-evaluated in the light of this recent work. In severely vitamin B12-deficient sheep, grazing on land deficient in cobalt, liver folic and folinic acid activity for L. casei and L. citrovorumr, respectively, plummet to very low levels (36) . 2) After an oral test dose of PGA, less folinic acid appears in the urine of pernicious anemia patients than in the urine of normal subjects (37) . In vitamin B12-deficient subjects previously treated with folic acid, the injection of 1 mg of vitamin B12 doubles the urinary folic acid activity excreted (38) . 3) Whole blood folic acid activity for S. faecalis appears to be low in onehalf of patients with pernicious anemia (39). 4) Large doses of folic acid will almost invariably induce at least temporary or partial hematologic remission in vitamin B12-deficient subjects (40) .
Conversely, large quantities of vitamin B12 will induce partial hematologic remission in subjects with folic acid deficiency (41). 5) Formiminoglutamic acid (FIGLU), an intermediate in the catabolism of histidine, found in the urine (sometimes only after an oral dose of histidine) in folic acid deficiency (42, 43) , also appears in the urine of some vitamin B.2-deficient subjects, sometimes in very large quantities (2, 14, 16, 21, 40, 44, 45) , and is generally present in large quantities in the urine of vitamin B12-deficient rats (46) and chicks (47) . Figure 4 presents, in abbreviated diagrammatic form, a hypothetical explanation 4 for the "piling up" of L. casei activity in serum and of FIGLU in urine in vitamin B12 deficiency. In this system, vitamin B12 acts as coenzyme and folic acid as substrate. If one considers the two agents to interact in this relationship, one has a facile explanation for the fact that a relatively small increase (to 400 /Ag) (48) above the approximate minimal daily requirement (50 jug) (19) for folic acid may produce hematologic response in pernicious anemia, whereas a much larger increase (to 100 to 500 ug) (41) above the approximate minimal daily requirement (0.1 ug) (49) for vitamin B12 appears necessary to produce a hematologic response in folic acid deficiency. Figure 4 may also explain the apparent decrease in FIGLU excretion by folic acid-deficient subjects when treated with 500 MAg of vitamin B12 daily (41 These studies support the possibility that the megaloblastic anemia which follows vitamin B12 deprivation may be partly the result of secondarily deranged folic acid metabolism. This may, in large measure, explain why the hematologic picture is the same in vitamin B12 deficiency as it is in folic acid deficiency. Much of this hematologic similarity may also be due to the fact that lack of either folic acid or vitamin B12 reduces thymidylate synthesis, as indicated in Figure 5 (51-56) .
SUMMARY
In slightly to severely anemic vitamin B12-deficient subjects, after the intravenous injection of 15 /Ag pteroylglutamic acid (PGA) per kg of body weight, folic acid activity for S. faecalis disappears rapidly but activity for L. casei disappears slowly from the serum.
Markedly elevated serum folic acid activity for L. casei (25 or more mug per ml) was observed in 17 of 100 consecutive subjects with vitamin B12 deficiency. During specific therapy with daily doses of 5 to 1,000 Mg of vitamin B12, serum folic acid activity for L. casei may fall sharply and may reach levels below normal before rising again into the normal range. The phenomenon may be due to release of the block in utilization of L. casei folic acid activity caused by lack of vitamin B12, with subsequent rapid utilization in hematopoiesis, and may be similar to the fall in serum iron during therapy. Serum folic acid activity for L. casei may fall more slowly during specific therapy with smaller (1 Mig) daily doses of vitamin B12. These findings suggest that in the vitamin B12-deficient subject, PGA is rapidly converted to an L. casei-active and presumably metabolically useful form (probably N5-methyl-tetrahydrofolic acid) which then "piles up" in the serum because vitamin B12 is required for its normal utilization. This "piled up" folate activity would tend to reduce the amount of folic acid available for other 1-carbon unit transfers. These studies, by providing evidence for the concept that vitamin B12 is required for normal folic acid metabolism, support the possibility that the apparent folic acid deficiency in many patients with vitamin B12 deficiency may be in large measure due to secondarily deranged folic acid metabolism.
Two minor observations of the present study were:
1. The intravenous injection of 15 Mtg of PGA per kg of body weight did not appear to affect significantly either the serum vitamin B12 level or the folic acid activity of the red cell for L. casei. The latter finding suggests that the mature erythrocyte is relatively impermeable to folic acid.
2. Folic acid activity for L. casei and vitamin B12 activity for E. gracilis both may be much higher in reticulocyte-rich than in reticulocyte-poor erythrocytes after vitamin B12 therapy. This suggests that the reticulocyte or its precursors, or both are relatively permeable to folic acid and vitamin B12.
